PDIA3 and Alzheimer disease: In this respect, we employed SH‐SY5Y neuroblastoma cells treated with micromolar amounts of Aβ25−35, a well‐established AD cellular model (Xicoy et al., 2017), to investigate the effects of aggregated Aβ25−35 on ERp57 protein levels and localization.